Category Archives: Stem Cell Research

"Atheism Alone Doesn't Make Anyone Special" [SofiaRune Mirror] Please watch the original video and subscribe to Sofia's channel at this link: http://www.youtube.com Original description: Secular groups in the US: American's United for the Separation of Church and State: http://www.au.org Talk To Action: http://www.talk2action.org Atheists denying climate change: Atheist Conservative: http://www.theatheistconservative.com http://www.theatheistconservative.com Another Libertarian Atheist: jdkolassa.net Religious Groups Recognizing Climate Change Micah Network Declaration: http://www.micahnetwork.org Christian Reformed Church: http://www.crcna.org Atheistic Pro-life Anti-Stem Cell Secular pro-life: secularprolife.org Atheist prolife: http://www.godlessprolifers.org Religious Pro-Choice and Pro-Stem Cell Unitarian Universalist Association of Congregations statement on stem cell research http://www.uua.org United Church of Christ on stem cell research http://www.ucc.org Religious Coalition for Reproductive Choice member list: http://www.rcrc.org Homophobic Atheists Black Atheist of Atlanta's infamous video (relevant timestamps 5:53, 7:03, 7:53) http://www.youtube.com Ayn Rand on homosexuality: http://www.atlassociety.org Homosexuality supporting religious groups: Metropolitan Community Church: mccchurch.org United Church of Canada: http://www.united-church.ca http://www.affirmunited.ca Quaker's advocating for same-sex marriage: http://www.quaker.org.uk Atheists believing in stupid shit: Christine Maggiore compares HIV/AIDS science to religion: http://www.aliveandwell.org News story about Christine Maggiore: http://www.guardian.co.uk More analysis on the ...From:Ujames1978LivesOnViews:14 2ratingsTime:17:49More inPeople Blogs More: "Atheism Alone Doesn't Make Anyone Special" [SofiaRune Mirror] - Video … Continue reading →

LONDON (Reuters) - Ten international drug companies are to team up with scientists from 11 European countries to create a bank of stem cells for a project aimed at speeding up the development of new medicines. StemBANCC, coordinated by Swiss drugmaker Roche and managed by scientists at Oxford University, aims to use so-called human-induced pluripotent stem cells - derived from people with hard-to-treat conditions - as research tools. Martin Graf from Roche, who is coordinating the project, said the goal was to generate 1,500 induced pluripotent stem cell lines derived from 500 patients that can then be used by researchers around the world to study a range of diseases, including diabetes and dementia. In recent years, researchers have developed a way of reprogramming ordinary adult cells taken from skin or blood, for example, to create stem cells that can be used to generate any type of cell. These induced pluripotent stem cells can offer a supply of different kinds of human cell such as cardiomyocytes, or heart cells, and neurons or nerve cells that can be used for a broad range of laboratory tests in early stage drug development. The research that resulted in the creation of the first induced … Continue reading →

LOS ANGELES (AP) California has transformed into a powerhouse player in stem cell research, but the taxpayer-funded institute responsible for that needs an overhaul, a report released Thursday found. The review by the Institute of Medicine lauded the California Institute for Regenerative Medicine for making the state a leader in the field by funneling research money with an eye toward stem cell therapies. But the report found too many members of the governing board represented schools that won funding and recommended a restructuring to avoid the appearance of conflict of interest. California voters in 2004 passed Proposition 71, a state ballot initiative that created CIRM, at a time when there were federal restrictions on human embryonic stem cell research and such work was opposed by some on religious and moral grounds because embryos have to be destroyed to harvest the cells. The agency was given broad power to distribute $3 billion in bond proceeds to promising research. So far, it has awarded $1.3 billion to nearly five dozen universities that went mostly to new buildings and basic research. The team of experts that reviewed the stem-cell agency's operations did not judge the merits of individual studies because it would have … Continue reading →

LOS ANGELES (AP) California has transformed into a powerhouse player in stem cell research, but the taxpayer-funded institute responsible for that needs an overhaul, a report released Thursday found. The review by the Institute of Medicine lauded the California Institute for Regenerative Medicine for making the state a leader in the field by funneling research money with an eye toward stem cell therapies. But the report found too many members of the governing board represented schools that won funding and recommended a restructuring to avoid the appearance of conflict of interest. California voters in 2004 approved Proposition 71, a state ballot initiative that created CIRM, at a time when there were federal restrictions on human embryonic stem cell research and such work was opposed by some on religious and moral grounds because embryos have to be destroyed to harvest the cells. The agency was given broad power to distribute $3 billion in bond proceeds to promising research. So far, it has distributed more than $1 billion to some five dozen universities that went mostly to funding new buildings and basic research. The team of 13 experts that reviewed the stem-cell agency's operations did not judge the merits of individual studies … Continue reading →

Roger De Felippo, MD, Principal Investigator in The Saban Research Institute Roger De Felippo, MD studies new uses of stem cells and other techniques for organ regeneration and cell therapeutics at Children's Hospital Los Angeles.From:childrensLAViews:1 0ratingsTime:01:34More inScience Technology Go here to read the rest: Roger De Felippo, MD, Principal Investigator in The Saban Research Institute - Video … Continue reading →

Stem Cell Research: Moving Forward The Role of Government 1 Presentation given on November 29, 2012From:thereveriepangViews:1 0ratingsTime:09:01More inEducation Visit link: Stem Cell Research: Moving Forward … Continue reading →

Advancing Stem Cell Research... Dr. Bernard Thbaud explains the potential of using cord blood derived stem cells to treat BPD (chronic lung disease) one day at the CHEO Research Institute.From:CHEOvideosViews:0 0ratingsTime:03:51More inScience Technology View original post here: Advancing Stem Cell Research... - Video … Continue reading →

"Ask the Experts - Living with ALS" Seminar at Cedars-Sinai Medical Center On Saturday, November 17, 2012, world-renowned researchers involved in the study of ALS participated in a this special event, "Ask the Experts -- Living with ALS" at Cedars-Sinai Medical Center in Los Angeles, California. The event, hosted by The ALS Association Golden West Chapter, offered people with ALS and their loved ones an opportunity to ask their questions directly to scientists and clinicians. Speakers include Catherine Lomen-Hoerth, MD, Ph.D., Director, The ALS Center at UCSF, who will discuss multidisciplinary care and ALS along with The ALS Association's Chief Scientist, Lucie Bruijn, Ph.D., who will present an overview of ALS research. Following these discussions, Robert H. Baloh, MD, Ph.D., Director, Cedars-Sinai ALS Center, Don W. Cleveland, Ph.D, Department Chair, UCSD, and Clive Svendsen, Ph.D., Director, Cedars-Sinai RMI and Chair of the California ALS Research Network will speak about topics such as clinical trials, genetics, and stem cell research. To find out more, please visit: http://www.alsagoldenwest.org or httpFrom:Calabasas3Views:7 0ratingsTime:02:57:25More inEducation Continue reading here: "Ask the Experts - Living with ALS" Seminar at Cedars-Sinai Medical Center - Video … Continue reading →

NEW YORK, NY and PETACH TIKVAH, ISRAEL--(Marketwire - Dec 4, 2012) - Sai Rosen of http://www.InvestorStemCell.com (Stem Cell Media, LLC) recently sat down with Dr. Adrian Harel, Chief Executive Officer for Brainstorm Cell Therapeutics Inc. ( OTCQB : BCLI ).Brainstorm Cell Therapeutics Inc. is a biotechnology company developing autologous stem cell therapies for highly debilitating neurodegenerative disorders, such as Amyotrophic Lateral Sclerosis (ALS) (Lou Gehrig's disease), Multiple Sclerosis (MS) and Parkinson's disease (PD) and Spinal Cord Injury. These diseases have limited treatment options and as such represent unmet medical needs. Dr. Harel has over 30 years' experience in international business development, marketing, clinical development, fund raising and building strategic partnerships. In January 2011, he came to Brainstorm and leveraged all his experience to transform the company from a struggling pre-clinical biotech to the world's leader in clinical stage neurodegenerative treatment for ALS.The company is nearing submission of an ALS Phase II, to be conducted at the renowned Massachusetts General Hospital (MGH). During his interview, Dr. Harel shared the following information: Why are you interested in neurodegenerative disorders? Dr. Harel: "I became fascinated in this area of research while working at Proneuron Biotechnologies.We had created the 'world center' for paralysis.I had … Continue reading →

TORONTO, ONTARIO--(Marketwire - Dec. 4, 2012) - Stem Cell Therapeutics Corp. (TSX VENTURE:SSS) ("SCT" or the "Company") a life sciences development company of stem cell-related therapeutics, today announced a reminder that a Special Meeting of Shareholders will be held in the Offices of McCarthy Ttrault LLP, Toronto Dominion Bank Tower, 66 Wellington Street West, 53rd Floor, J.J. Robinette Boardroom, Toronto, ON M5K 1E6, on Thursday, December 20, 2012, at 10:00 a.m. Eastern Time. The Special Meeting will consider resolutions set forth in the Management Information Circular dated November 22, 2012, accessible on SEDAR at http://www.sedar.com. Interested shareholders, unable to attend the meeting in person, can listen to the proceedings live via conference call. Stem Cell Therapeutics has provided a corporate update for its shareholders, which is available on the Investors page of the Company's website: http://www.stemcellthera.com. Mr. David Allan, Executive Chairman of Stem Cell Therapeutics will also host a question and answer session following the Special Meeting. Conference call participants wishing to ask a question will be instructed by the operator on how to do so at this time. Details to listen live: About Stem Cell Therapeutics Stem Cell Therapeutics Corp. (TSX VENTURE:SSS) is a Canadian commercialization receptor company in … Continue reading →